Northpointe Capital’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-232,823
Closed -$1.57M 149
2018
Q4
$1.57M Sell
232,823
-101,221
-30% -$736K 0.35% 118
2018
Q3
$2.72M Sell
334,044
-78,089
-19% -$730K 0.39% 126
2018
Q2
$3.96M Buy
412,133
+168,063
+69% +$1.61M 0.52% 77
2018
Q1
$2.44M Buy
+244,070
New +$1.89M 0.31% 139

Other funds holding ULBI

Northpointe Capital's ULBI Position: Q1 2019 in Review

Northpointe Capital sold out of Ultralife (ULBI) in Q1 2019, closing a stake of 232,823 shares — an estimated $1.57M sold.

Northpointe Capital first reported a position in ULBI in Q1 2018 and held it in 4 quarters. The position peaked at $3.96M in Q2 2018. 40 funds tracked by Wall St. Rank hold ULBI as of Q1 2019.

  • Northpointe Capital reported no remaining Ultralife position as of Q1 2019 after selling out during the quarter.
  • Northpointe Capital sold 232,823 Ultralife shares in Q1 2019, an estimated $1.57M.
  • Northpointe Capital first reported a position in Ultralife in Q1 2018 and held it in 4 quarters.
  • Northpointe Capital's Ultralife position peaked at $3.96M in Q2 2018.
  • 40 funds tracked by Wall St. Rank held Ultralife as of Q1 2019.

Based on Northpointe Capital's 13F filing for Q1 2019, filed 17 Apr 2019.